Covered recipient · General Payments record
MICHELLE MARTINEZ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2023
$283.31
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $283.31 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $157.42 | 3 |
| Novo Nordisk AS | $39.08 | 2 |
| SANOFI-AVENTIS U.S. LLC | $23.22 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $18.26 | 1 |
| Exact Sciences Corporation | $17.53 | 1 |
| PFIZER INC. | $14.63 | 1 |
| Amgen Inc. | $13.17 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2023 | $283.31 | 10 |
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $13.17 | 06/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020784559 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.99 | 06/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015865249 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.59 | 08/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014927881 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.84 | 10/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014506827 | CMS |
| Exact Sciences Corporation | $17.53 | 04/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026864385 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $18.26 | 07/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034263949 | CMS |
| Novo Nordisk Inc | $22.52 | 08/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002865179 | CMS |
| Novo Nordisk Inc | $16.56 | 10/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002865169 | CMS |
| PFIZER INC. | $14.63 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049312691 | CMS |
| SANOFI-AVENTIS U.S. LLC | $23.22 | 04/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050026827 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023
- Source files
- Dataset page · Bulk file · PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.